Skip to content
Search

Latest Stories

Boris Johnson urges global effort at vaccine summit

British prime minister Boris Johnson called for a "new era of global health co-operation" as he prepared to host a vaccine fundraising summit on Thursday under the shadow of coronavirus.

The virtual meeting aims to raise $7.4 billion for immunisation programmes stalled by the pandemic, and will see the launch of a new fundraising drive to support potential COVID-19 vaccines.


"I hope this summit will be the moment when the world comes together to unite humanity in the fight against disease," Johnson said in a statement.

The British leader added he hoped it would "inaugurate a new era of global health co-operation, which I believe is now the most essential shared endeavour of our lifetimes".

More than 50 countries are taking part in Thursday's meeting, as well as individuals such as philanthropist Bill Gates, and will raise funds for Gavi, the vaccine alliance.

Over the next five years, it wants to reboot halted programmes and provide vaccines at a much-reduced cost to some 300 million children.

Gavi and its partners will also launch a financing drive to purchase potential COVID-19 vaccines, scale-up their production and support delivery to developing nations.

The pandemic has exposed new ruptures in international cooperation, notably with US President Donald Trump's decision to pull out of the World Health Organization (WHO).

But Johnson said helping developing countries would benefit places such as Britain, which has suffered the worst coronavirus death toll in Europe.

"This support for routine immunisations will shore up poorer countries' healthcare systems to deal with coronavirus -- and so help to stop the global spread," he told reporters on Wednesday.

"This virus has shown how connected we are. We're fighting an invisible enemy. And no one is safe frankly until we are all safe."

- All at risk -

Gates said that pharmaceutical companies had been working together to try and secure the required production capacity.

"It's been amazing, the pharmaceutical companies stepping up to say 'yes, even if our vaccine is not the best, we will make our factories available'," he told BBC Radio 4.

"If you only have one factory, and it's only making say 300 million doses a year, then the scramble for that would be very difficult.

"If you can get 10 of those factories and get three billion a year, then it's not nearly as difficult."

The coronavirus pandemic has killed more than 380,000 people since it emerged in China last December, according to an AFP tally of official sources.

Stay-at-home orders were imposed across the world, causing huge economic disruption and the suspension of many routine immunisation services.

The WHO, UN children's agency UNICEF and Gavi warned last month that vaccine services were disrupted in nearly 70 countries, affecting some 80 million children under the age of one.

Polio eradication drives were suspended in dozens of countries, while measles vaccination campaigns were also put on hold in 27 countries, UNICEF said.

Recent Gavi-supported modelling from the London School of Hygiene and Tropical Medicine estimated that for every coronavirus death prevented by halting vaccination campaigns in Africa, up to 140 people could die from vaccine-preventable diseases.

"More children in more countries are now protected against more diseases than at any point in history," said Seth Berkley, chief executive of Gavi.

"However, these historic advances in global health are now at risk of unravelling as COVID-19 causes unprecedented disruption to vaccine programmes worldwide.

"We face the very real prospect of a global resurgence of diseases like measles, polio and yellow fever, which would put us all at risk."

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less